EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Beyond amyloid plaque, targeting α-synuclein in Alzheimer disease: The battle continues

Hayder M Al-Kuraishy, Ghassan M Sulaiman, Hamdoon A Mohammed, Ali I Al-Gareeb, Ali K Albuhadily, Amer Al Ali, Mohammed H Abu-Alghayth

Ageing Research Reviews · 2025-03 · 105 · 102684

DOI: 10.1016/j.arr.2025.102684 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2025-03. Verfasst von Hayder M Al-Kuraishy und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical pharmacology and Medicine, College of Medicine, Mustansiriyah University, Baghdad 14022, Iraq. Hauptthemen laut MEDLINE: Alzheimer Disease, alpha-Synuclein, Plaque, Amyloid, Brain. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 162 Literaturangaben. Gefördert von: University of Bisha.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is the most common neurodegenerative brain disease and represents the most frequent type of dementia characterized by cognitive impairment and amnesia. AD neuropathology is connected to the development of synaptic dysfunction and loss of synaptic homeostasis due to an imbalance in the production and clearance of β-amyloid (Aβ) and intracellular neurofibrillary tangles (NFTs). However, AD neuropathology is complex and may relate to the deposition of other misfolded proteins, such as alpha-synuclein (α-Syn). Of note, α-Syn, which is involved in the pathogenesis of Parkinson disease (PD) and Lewy body (LB) dementia, is also implicated in AD neuropathology. However, the potential role of α-Syn in AD neuropathology is elusive. Therefore, this review aims to discuss the pathological role of α-Syn in AD and how targeting α-Syn aggregates may be effective in treating AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer Diseasealpha-SynucleinPlaque, AmyloidBrainHumansAnimalsAmyloid beta-Peptides

Stichwörter der Autor:innen

Alzheimer diseaseNeurodegenerative diseaseNeuropathologyPathogenesisα-Synβ-amyloid

Substanzen

alpha-SynucleinAmyloid beta-Peptides

Autor:innen und Institutionen

  • Department of Clinical pharmacology and Medicine, College of Medicine, Mustansiriyah University, Baghdad 14022, Iraq.
  • Department of Applied Sciences, University of Technology, Baghdad 10066, Iraq. Electronic address: ghassan.m.sulaiman@uotechnology.edu.iq.
  • Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Qassim University, Qassim 51452, Saudi Arabia.
  • Department of Clinical pharmacology and Medicine, College of Medicine, Jabir ibn Hayyan Medical University, Kufa, Najaf 54001, Iraq.
  • Department of Medical Laboratory Sciences, College of Applied Medical Sciences, University of Bisha, 255, Al Nakhil, Bisha 67714, Saudi Arabia.

Förderung

  • University of Bisha

Zitieren

APA

Al-Kuraishy, H. M., Sulaiman, G. M., Mohammed, H. A., Al-Gareeb, A. I., Albuhadily, A. K., Ali, A. A., & Abu-Alghayth, M. H. (2025). Beyond amyloid plaque, targeting α-synuclein in Alzheimer disease: The battle continues. Ageing Research Reviews, 105, 102684. https://doi.org/10.1016/j.arr.2025.102684

Vancouver

Al-Kuraishy HM, Sulaiman GM, Mohammed HA, Al-Gareeb AI, Albuhadily AK, Ali AA, et al. Beyond amyloid plaque, targeting α-synuclein in Alzheimer disease: The battle continues. Ageing Research Reviews. 2025;105:102684. doi:10.1016/j.arr.2025.102684

BibTeX
@article{AlKuraishy2025,
  author = {Al-Kuraishy, Hayder M and Sulaiman, Ghassan M and Mohammed, Hamdoon A and Al-Gareeb, Ali I and Albuhadily, Ali K and Ali, Amer Al and Abu-Alghayth, Mohammed H},
  title = {Beyond amyloid plaque, targeting α-synuclein in Alzheimer disease: The battle continues},
  journal = {Ageing Research Reviews},
  year = {2025},
  volume = {105},
  pages = {102684},
  doi = {10.1016/j.arr.2025.102684}
}
Kostenlos starten →